Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Overcoming Fear of ‘CPV Monster,’ Drug Makers Launch Continued Process Verification Programs

This article was originally published in The Gold Sheet

Executive Summary

Most pharmaceutical manufacturers are adopting or making plans to adopt the continued process verification approach outlined in FDA’s November 2011 process validation guidance, which will shine a light on their manufacturing processes. But not everyone is anxious to see what that light will reveal.

You may also be interested in...



CPV Shines New Light on Old Manufacturing Processes

Biopharmaceutical manufacturers say that implementation of continued process verification has helped to update “archaic” manufacturing processes for legacy products and uncover problems with raw materials. They have reaped some business benefits as well.

FDA’s Quality Metrics Proposal Poses Challenges, Including Gaming, Cost

If it works, the quality metrics initiative outlined in draft FDA guidance will help the global pharmaceutical supply chain prevent quality failures and drug shortages. But there will be challenges.

FDA’s Quality Metrics Proposal Poses Challenges, Including 'Gaming,' Cost

If it works, tracking the four quality metrics outlined in FDA guidance will help the global pharmaceutical supply chain prevent quality failures and drug shortages.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS000917

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel